title: The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor.
authors.forename: H
authors.initials: H
authors.lastname: Pergantou
authors.forename: P
authors.initials: P
authors.lastname: Xafaki
authors.forename: E
authors.initials: E
authors.lastname: Adamtziki
authors.forename: P
authors.initials: P
authors.lastname: Koletsi
authors.forename: A
authors.initials: A
authors.lastname: Komitopoulou
authors.forename: H
authors.initials: H
authors.lastname: Platokouki
mesh_terms: D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome; D056729:von Willebrand Disease, Type 3 / Q000188:drug therapy / Q000276:immunology*; D014841:von Willebrand Factor / Q000276:immunology*
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D014841:von Willebrand Factor